GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kyung Dong Pharmaceutical Co Ltd (XKRX:011040) » Definitions » Return-on-Tangible-Equity

Kyung Dong Pharmaceutical Co (XKRX:011040) Return-on-Tangible-Equity : 0.13% (As of Sep. 2024)


View and export this data going back to 1992. Start your Free Trial

What is Kyung Dong Pharmaceutical Co Return-on-Tangible-Equity?

Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Kyung Dong Pharmaceutical Co's annualized net income for the quarter that ended in Sep. 2024 was ₩287 Mil. Kyung Dong Pharmaceutical Co's average shareholder tangible equity for the quarter that ended in Sep. 2024 was ₩212,766 Mil. Therefore, Kyung Dong Pharmaceutical Co's annualized Return-on-Tangible-Equity for the quarter that ended in Sep. 2024 was 0.13%.

The historical rank and industry rank for Kyung Dong Pharmaceutical Co's Return-on-Tangible-Equity or its related term are showing as below:

XKRX:011040' s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -8.69   Med: 6.22   Max: 13.9
Current: -7.74

During the past 13 years, Kyung Dong Pharmaceutical Co's highest Return-on-Tangible-Equity was 13.90%. The lowest was -8.69%. And the median was 6.22%.

XKRX:011040's Return-on-Tangible-Equity is ranked worse than
74.89% of 912 companies
in the Drug Manufacturers industry
Industry Median: 6.42 vs XKRX:011040: -7.74

Kyung Dong Pharmaceutical Co Return-on-Tangible-Equity Historical Data

The historical data trend for Kyung Dong Pharmaceutical Co's Return-on-Tangible-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kyung Dong Pharmaceutical Co Return-on-Tangible-Equity Chart

Kyung Dong Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Return-on-Tangible-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.31 5.15 4.90 4.76 -8.69

Kyung Dong Pharmaceutical Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Return-on-Tangible-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.90 -34.25 2.40 2.78 0.13

Competitive Comparison of Kyung Dong Pharmaceutical Co's Return-on-Tangible-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, Kyung Dong Pharmaceutical Co's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kyung Dong Pharmaceutical Co's Return-on-Tangible-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kyung Dong Pharmaceutical Co's Return-on-Tangible-Equity distribution charts can be found below:

* The bar in red indicates where Kyung Dong Pharmaceutical Co's Return-on-Tangible-Equity falls into.



Kyung Dong Pharmaceutical Co Return-on-Tangible-Equity Calculation

Kyung Dong Pharmaceutical Co's annualized Return-on-Tangible-Equity for the fiscal year that ended in Dec. 2023 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets )/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=-20707.555/( (254314.94+222490.093 )/ 2 )
=-20707.555/238402.5165
=-8.69 %

Kyung Dong Pharmaceutical Co's annualized Return-on-Tangible-Equity for the quarter that ended in Sep. 2024 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(Q: Sep. 2024 )  (Q: Jun. 2024 )(Q: Sep. 2024 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets)/ count )
(Q: Sep. 2024 )  (Q: Jun. 2024 )(Q: Sep. 2024 )
=286.86/( (212550.663+212981.79)/ 2 )
=286.86/212766.2265
=0.13 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Sep. 2024) net income data. Return-on-Tangible-Equity is displayed in the 10-year financial page.


Kyung Dong Pharmaceutical Co  (XKRX:011040) Return-on-Tangible-Equity Explanation

Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.


Be Aware

Net Income is used.

Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.


Kyung Dong Pharmaceutical Co Return-on-Tangible-Equity Related Terms

Thank you for viewing the detailed overview of Kyung Dong Pharmaceutical Co's Return-on-Tangible-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Kyung Dong Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
1926, Nambusunhwan-ro, Gwanak-gu, Seoul, KOR
Kyung Dong Pharmaceutical Co Ltd is a South Korea-based company engaged in the manufacturing and marketing of pharmaceutical products. Its products include liver therapies, gastrointestinal drugs, antimigraine drugs, antiviral, anti-obesity medications, antibacterial drugs, antidiabetic drugs, antifungal, vitamins, as well as drugs for osteoporosis, cardiovascular, muscle relaxant, neuropathic and other diseases.

Kyung Dong Pharmaceutical Co Headlines

No Headlines